115 related articles for article (PubMed ID: 23062926)
21. [Subcutaneous Rituximab is effective and safe].
Häckel A
Med Monatsschr Pharm; 2014 Jan; 37(1):39-40. PubMed ID: 24490439
[No Abstract] [Full Text] [Related]
22. Sustained response of refractory chronic lymphocytic leukemia in progression complicated by acute hemolitic anemia to anti-CD20 monoclonal antibody.
Iannitto E; Ammatuna E; Marino C; Cirrincione S; Greco G; Mariani G
Blood; 2002 Feb; 99(3):1096-7. PubMed ID: 11822361
[No Abstract] [Full Text] [Related]
23. Chronic lymphocytic leukemia-associated immune thrombocytopenia treated with rituximab: a retrospective study of 21 patients.
D'Arena G; Capalbo S; Laurenti L; Del Poeta G; Nunziata G; Deaglio S; Spinosa G; Tarnani M; De Padua L; Califano C; Ferrara F; Cascavilla N
Eur J Haematol; 2010 Dec; 85(6):502-7. PubMed ID: 20846302
[TBL] [Abstract][Full Text] [Related]
24. Macrophage activation syndrome leading to fatality in subcutaneous panniculitis-like T cell lymphoma.
Kwok G; Loong F; Wong CS; Leung RY; Shek TW; Kwong YL
Ann Hematol; 2014 May; 93(5):873-5. PubMed ID: 23995578
[No Abstract] [Full Text] [Related]
25. Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy.
Pei SN; Ma MC; Wang MC; Kuo CY; Rau KM; Su CY; Chen CH
Ann Hematol; 2012 Jul; 91(7):1007-12. PubMed ID: 22273839
[TBL] [Abstract][Full Text] [Related]
26. Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice.
Zaja F; Mian M; Volpetti S; Visco C; Sissa C; Nichele I; Castelli M; Ambrosetti A; Puglisi S; Fanin R; Cortelazzo S; Pizzolo G; Trentin L; Rodeghiero F; Paolini R; Vivaldi P; Sancetta R; Isola M; Semenzato G
Am J Hematol; 2013 Nov; 88(11):955-60. PubMed ID: 23861234
[TBL] [Abstract][Full Text] [Related]
27. Subcutaneous panniculitis-like T-cell lymphoma in a 19 month-old boy: a case report.
Rajić L; Bilić E; Femenić R; Mestrović D; Ilić I; Lasan-Trcić R; Dubravcić K; Husar K; Kardum-Skelin I; Tesović G; Culig Z; Konja J
Coll Antropol; 2010 Jun; 34(2):679-82. PubMed ID: 20698153
[TBL] [Abstract][Full Text] [Related]
28. Population pharmacokinetics of rituximab in patients with chronic lymphocytic leukemia.
Li J; Zhi J; Wenger M; Valente N; Dmoszynska A; Robak T; Mangat R; Joshi A; Visich J
J Clin Pharmacol; 2012 Dec; 52(12):1918-26. PubMed ID: 22235140
[TBL] [Abstract][Full Text] [Related]
29. Subcutaneous panniculitis-like T-cell lymphoma in a 26-month-old child with a review of the literature.
Yim JH; Kim MY; Kim HO; Cho B; Chung NG; Park YM
Pediatr Dermatol; 2006; 23(6):537-40. PubMed ID: 17155994
[TBL] [Abstract][Full Text] [Related]
30. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
[TBL] [Abstract][Full Text] [Related]
31. Subcutaneous panniculitis-like T-cell lymphoma during pregnancy with successful autologous stem cell transplantation.
Reimer P; Rüdiger T; Müller J; Rose C; Wilhelm M; Weissinger F
Ann Hematol; 2003 May; 82(5):305-9. PubMed ID: 12707721
[TBL] [Abstract][Full Text] [Related]
32. Rituximab in the treatment of non-Hodgkin's lymphoma--a critical evaluation of randomized controlled trials.
Griffin MM; Morley N
Expert Opin Biol Ther; 2013 May; 13(5):803-11. PubMed ID: 23560506
[TBL] [Abstract][Full Text] [Related]
33. Thoracic subcutaneous infiltration: an unusual presentation of subcutaneous panniculitis-like T-cell lymphoma.
Ballanger F; Barbarot S; Le Gouill S; Gaillard F; Cassagnau E; Lodé L; Dréno B; Stalder JF
Acta Derm Venereol; 2009; 89(4):427-9. PubMed ID: 19688166
[No Abstract] [Full Text] [Related]
34. Severe thrombocytopenia and clinical bleeding associated with rituximab infusion in a lymphoma patient with massive splenomegaly without leukemic invasion.
Rigamonti C; Volta C; Colombi S; Forti L; Savinelli F; Gaidano G; Bartoli E
Leukemia; 2001 Jan; 15(1):186-7. PubMed ID: 11243389
[No Abstract] [Full Text] [Related]
35. Aggressive subcutaneous panniculitis-like T-cell lymphoma with hemophagocytosis in two children (subcutaneous panniculitis-like T-cell lymphoma).
Koh MJ; Sadarangani SP; Chan YC; Chan MY; Tan AM; Tan SH; Tay YK; Ng SB
J Am Acad Dermatol; 2009 Nov; 61(5):875-81. PubMed ID: 19744747
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of bendamustine in rituximab-refractory indolent B-cell non-Hodgkin lymphoma: review of a pivotal trial.
Ujjani C; Cheson B
Future Oncol; 2011 Jan; 7(1):9-14. PubMed ID: 21174533
[TBL] [Abstract][Full Text] [Related]
37. Effective treatment of leukemia cutis with combination of rituximab, cladribine, and cyclophosphamide in patient with B-cell chronic lymphocytic leukemia.
Batycka-Baran A; Baran W; Dzietczenia J; Mazur G
Ann Hematol; 2011 Aug; 90(8):979-80. PubMed ID: 20978760
[No Abstract] [Full Text] [Related]
38. [Successful treatment with rituximab for autoimmune hemolytic anemia associated with chronic lymphocytic leukemia].
Tanaka Y; Ito Y; Yoshizawa S; Fujimoto H; Gotoh M; Tauchi T; Kimura Y; Ohyashiki K
Rinsho Ketsueki; 2013 Feb; 54(2):229-31. PubMed ID: 23470833
[TBL] [Abstract][Full Text] [Related]
39. Neutropenia associated with rituximab therapy.
Grant C; Wilson WH; Dunleavy K
Curr Opin Hematol; 2011 Jan; 18(1):49-54. PubMed ID: 21102324
[TBL] [Abstract][Full Text] [Related]
40. Agranulocytosis occurring in a patient with chronic lymphocytic leukemia in complete remission; treatment by rituximab and cyclosporin.
Costello RT; Sébahoun G
Leuk Res; 2010 Dec; 34(12):e329-30. PubMed ID: 20723978
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
